The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.

Toon andere (1) versies

BACKGROUND: Lowering LDL cholesterol with statin regimens reduces the risk of myocardial infarction, ischaemic stroke, and the need for coronary revascularisation in people without kidney disease, but its effects in people with moderate-to-severe kidney disease are uncertain. The SHARP trial aimed t...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs: Baigent, C, Landray, M, Reith, C, Emberson, J, Wheeler, D, Tomson, C, Wanner, C, Krane, V, Cass, A, Craig, J, Neal, B, Jiang, L, Hooi, L, Levin, A, Agodoa, L, Gaziano, M, Kasiske, B, Walker, R, Massy, Z, Feldt-Rasmussen, B, Krairittichai, U, Ophascharoensuk, V, Fellström, B, Holdaas, H, Tesar, V
Formaat: Journal article
Taal:English
Gepubliceerd in: 2011

Gelijkaardige items